Belite Bio: Funding, Investors & Team (Oct 2026)
Belite Bio specializes in creating innovative treatments for rare genetic diseases and age-related metabolic disorders such as atrophic age-related macular degeneration, stargardt disease, and nonalcoholic steatohepatitis. They are developing therapies targeting the protein RBP4 to address conditions like macular degeneration, liver disease, and diabetes by reducing levels of this protein linked to the development of these diseases.
Belite Bio has raised $380M across 3 funding rounds on record, the most recent an undisclosed round of $350M announced in Dec 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Belite Bio Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Belite Bio Funding Rounds
Belite Bio raised $15.0M in an undisclosed round announced in Feb 2025.
6 months later, an undisclosed round of $15.0M was announced in Aug 2025.
4 months later, an undisclosed round of $350M was announced in Dec 2025.
Belite Bio Founders and Leadership Team
Contact details for the Belite Bio team: 1 of 1 has an email address on file.
Start 14-day free trial →Belite Bio Funding Compared to Other Biotechnology Startups
Belite Bio's latest round of $350M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Belite Bio in Biotechnology and San Diego
Companies Similar to Belite Bio
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Belite Bio Funding FAQs
What does Belite Bio do?
Belite Bio specializes in creating innovative treatments for rare genetic diseases and age-related metabolic disorders such as atrophic age-related macular degeneration, stargardt disease, and nonalcoholic steatohepatitis. They are developing therapies targeting the protein RBP4 to address conditions like macular degeneration, liver disease, and diabetes by reducing levels of this protein linked to the development of these diseases.
How much funding has Belite Bio raised?
Belite Bio has raised $380M across 3 rounds on record. The most recent is an undisclosed round of $350M announced in Dec 2025.
When did Belite Bio last raise funding?
Belite Bio's most recent funding round on record is an undisclosed round of $350M, announced in Dec 2025.
Who founded Belite Bio?
FundedIQ lists Tom Lin (Founder) at Belite Bio.
Where is Belite Bio headquartered?
Belite Bio is based in San Diego, California, United States.
How many employees does Belite Bio have?
Belite Bio is in the 11-50 employee band.
How does Belite Bio's funding compare to other Biotechnology startups?
Belite Bio's latest round of $350M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Belite Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Belite Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.